 | • レポートコード：D0GIR-02659 • 出版社/出版日：GlobalInfoResearch / 2020年9月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール • 産業分類：New Technology |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、新型コロナウイルス感染症組換えタンパク質ワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。新型コロナウイルス感染症組換えタンパク質ワクチンの種類別市場規模（開発中、前臨床、臨床I、臨床II）、用途別市場規模（製薬・バイオテクノロジー企業、病院、学術・研究機関、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：GSK、Novavax、Johnson & Johnson、Suzhou Yuzhibo Biotechnology、Sanofi、Clover Biopharmaceuticals、Pukang Biologic Technology ・地域別グローバル市場分析 2015年-2020年 ・新型コロナウイルス感染症組換えタンパク質ワクチンの北米市場（アメリカ、カナダ、メキシコ） ・新型コロナウイルス感染症組換えタンパク質ワクチンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・新型コロナウイルス感染症組換えタンパク質ワクチンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・新型コロナウイルス感染症組換えタンパク質ワクチンの南米市場（ブラジル、アルゼンチン） ・新型コロナウイルス感染症組換えタンパク質ワクチンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：開発中、前臨床、臨床I、臨床II ・用途別分析：製薬・バイオテクノロジー企業、病院、学術・研究機関、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The COVID-19 Recombinant Protein Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global COVID-19 Recombinant Protein Vaccine sales will be xx in 2020 from COVID-19 Recombinant Protein Vaccine million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global COVID-19 Recombinant Protein Vaccine market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the COVID-19 Recombinant Protein Vaccine industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on COVID-19 Recombinant Protein Vaccine and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
COVID-19 Recombinant Protein Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, COVID-19 Recombinant Protein Vaccine market has been segmented into:
Being Developed
Preclinical
Clinical I
Clinical II
By Application, COVID-19 Recombinant Protein Vaccine has been segmented into:
Pharmaceutical And Biotechnology Companies
Hospital
Academic And Research Organizations
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global COVID-19 Recombinant Protein Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level COVID-19 Recombinant Protein Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global COVID-19 Recombinant Protein Vaccine market.
The report offers in-depth assessment of the growth and other aspects of the COVID-19 Recombinant Protein Vaccine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and COVID-19 Recombinant Protein Vaccine Market Share Analysis
COVID-19 Recombinant Protein Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, COVID-19 Recombinant Protein Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the COVID-19 Recombinant Protein Vaccine sales, revenue and market share for each player covered in this report.
The major players covered in COVID-19 Recombinant Protein Vaccine are:
GSK
Novavax
Johnson & Johnson
Suzhou Yuzhibo Biotechnology
Sanofi
Clover Biopharmaceuticals
Pukang Biologic Technology
Among other players domestic and global, COVID-19 Recombinant Protein Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 COVID-19 Recombinant Protein Vaccine Market Overview
1.1 Product Overview and Scope of COVID-19 Recombinant Protein Vaccine
1.2 Classification of COVID-19 Recombinant Protein Vaccine by Type
1.2.1 Global COVID-19 Recombinant Protein Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global COVID-19 Recombinant Protein Vaccine Revenue Market Share by Type in 2019
1.2.3 Being Developed
1.2.4 Preclinical
1.2.5 Clinical I
1.2.6 Clinical II
1.3 Global COVID-19 Recombinant Protein Vaccine Market by Application
1.3.1 Overview: Global COVID-19 Recombinant Protein Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Pharmaceutical And Biotechnology Companies
1.3.3 Hospital
1.3.4 Academic And Research Organizations
1.3.5 Other
1.4 Global COVID-19 Recombinant Protein Vaccine Market by Regions
1.4.1 Global COVID-19 Recombinant Protein Vaccine Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of COVID-19 Recombinant Protein Vaccine (2015-2025)
1.4.3 North America (USA, Canada and Mexico) COVID-19 Recombinant Protein Vaccine Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) COVID-19 Recombinant Protein Vaccine Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) COVID-19 Recombinant Protein Vaccine Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) COVID-19 Recombinant Protein Vaccine Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) COVID-19 Recombinant Protein Vaccine Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: COVID-19 Recombinant Protein Vaccine Industry Impact
1.5.1 COVID-19 Potential Implications for the COVID-19 Recombinant Protein Vaccine
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on COVID-19 Recombinant Protein Vaccine
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GSK SWOT Analysis
2.1.4 GSK Product and Services
2.1.5 GSK COVID-19 Recombinant Protein Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.2 Novavax
2.2.1 Novavax Details
2.2.2 Novavax Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Novavax SWOT Analysis
2.2.4 Novavax Product and Services
2.2.5 Novavax COVID-19 Recombinant Protein Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Johnson & Johnson SWOT Analysis
2.3.4 Johnson & Johnson Product and Services
2.3.5 Johnson & Johnson COVID-19 Recombinant Protein Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.4 Suzhou Yuzhibo Biotechnology
2.4.1 Suzhou Yuzhibo Biotechnology Details
2.4.2 Suzhou Yuzhibo Biotechnology Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Suzhou Yuzhibo Biotechnology SWOT Analysis
2.4.4 Suzhou Yuzhibo Biotechnology Product and Services
2.4.5 Suzhou Yuzhibo Biotechnology COVID-19 Recombinant Protein Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Sanofi SWOT Analysis
2.5.4 Sanofi Product and Services
2.5.5 Sanofi COVID-19 Recombinant Protein Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.6 Clover Biopharmaceuticals
2.6.1 Clover Biopharmaceuticals Details
2.6.2 Clover Biopharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Clover Biopharmaceuticals SWOT Analysis
2.6.4 Clover Biopharmaceuticals Product and Services
2.6.5 Clover Biopharmaceuticals COVID-19 Recombinant Protein Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.7 Pukang Biologic Technology
2.7.1 Pukang Biologic Technology Details
2.7.2 Pukang Biologic Technology Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Pukang Biologic Technology SWOT Analysis
2.7.4 Pukang Biologic Technology Product and Services
2.7.5 Pukang Biologic Technology COVID-19 Recombinant Protein Vaccine Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global COVID-19 Recombinant Protein Vaccine Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 COVID-19 Recombinant Protein Vaccine Players Market Share
3.2.2 Top 10 COVID-19 Recombinant Protein Vaccine Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global COVID-19 Recombinant Protein Vaccine Revenue and Market Share by Regions
4.2 North America COVID-19 Recombinant Protein Vaccine Revenue and Growth Rate (2015-2020)
4.3 Europe COVID-19 Recombinant Protein Vaccine Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific COVID-19 Recombinant Protein Vaccine Revenue and Growth Rate (2015-2020)
4.5 South America COVID-19 Recombinant Protein Vaccine Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa COVID-19 Recombinant Protein Vaccine Revenue and Growth Rate (2015-2020)
5 North America COVID-19 Recombinant Protein Vaccine Revenue by Countries
5.1 North America COVID-19 Recombinant Protein Vaccine Revenue by Countries (2015-2020)
5.2 USA COVID-19 Recombinant Protein Vaccine Revenue and Growth Rate (2015-2020)
5.3 Canada COVID-19 Recombinant Protein Vaccine Revenue and Growth Rate (2015-2020)
5.4 Mexico COVID-19 Recombinant Protein Vaccine Revenue and Growth Rate (2015-2020)
6 Europe COVID-19 Recombinant Protein Vaccine Revenue by Countries
6.1 Europe COVID-19 Recombinant Protein Vaccine Revenue by Countries (2015-2020)
6.2 Germany COVID-19 Recombinant Protein Vaccine Revenue and Growth Rate (2015-2020)
6.3 UK COVID-19 Recombinant Protein Vaccine Revenue and Growth Rate (2015-2020)
6.4 France COVID-19 Recombinant Protein Vaccine Revenue and Growth Rate (2015-2020)
6.5 Russia COVID-19 Recombinant Protein Vaccine Revenue and Growth Rate (2015-2020)
6.6 Italy COVID-19 Recombinant Protein Vaccine Revenue and Growth Rate (2015-2020)
7 Asia-Pacific COVID-19 Recombinant Protein Vaccine Revenue by Countries
7.1 Asia-Pacific COVID-19 Recombinant Protein Vaccine Revenue by Countries (2015-2020)
7.2 China COVID-19 Recombinant Protein Vaccine Revenue and Growth Rate (2015-2020)
7.3 Japan COVID-19 Recombinant Protein Vaccine Revenue and Growth Rate (2015-2020)
7.4 Korea COVID-19 Recombinant Protein Vaccine Revenue and Growth Rate (2015-2020)
7.5 India COVID-19 Recombinant Protein Vaccine Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia COVID-19 Recombinant Protein Vaccine Revenue and Growth Rate (2015-2020)
8 South America COVID-19 Recombinant Protein Vaccine Revenue by Countries
8.1 South America COVID-19 Recombinant Protein Vaccine Revenue by Countries (2015-2020)
8.2 Brazil COVID-19 Recombinant Protein Vaccine Revenue and Growth Rate (2015-2020)
8.3 Argentina COVID-19 Recombinant Protein Vaccine Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue COVID-19 Recombinant Protein Vaccine by Countries
9.1 Middle East & Africa COVID-19 Recombinant Protein Vaccine Revenue by Countries (2015-2020)
9.2 Saudi Arabia COVID-19 Recombinant Protein Vaccine Revenue and Growth Rate (2015-2020)
9.3 UAE COVID-19 Recombinant Protein Vaccine Revenue and Growth Rate (2015-2020)
9.4 Egypt COVID-19 Recombinant Protein Vaccine Revenue and Growth Rate (2015-2020)
9.5 South Africa COVID-19 Recombinant Protein Vaccine Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global COVID-19 Recombinant Protein Vaccine Revenue and Market Share by Type (2015-2020)
10.2 Global COVID-19 Recombinant Protein Vaccine Market Forecast by Type (2019-2024)
10.3 Being Developed Revenue Growth Rate (2015-2025)
10.4 Preclinical Revenue Growth Rate (2015-2025)
10.5 Clinical I Revenue Growth Rate (2015-2025)
10.6 Clinical II Revenue Growth Rate (2015-2025)
11 Global COVID-19 Recombinant Protein Vaccine Market Segment by Application
11.1 Global COVID-19 Recombinant Protein Vaccine Revenue Market Share by Application (2015-2020)
11.2 COVID-19 Recombinant Protein Vaccine Market Forecast by Application (2019-2024)
11.3 Pharmaceutical And Biotechnology Companies Revenue Growth (2015-2020)
11.4 Hospital Revenue Growth (2015-2020)
11.5 Academic And Research Organizations Revenue Growth (2015-2020)
11.6 Other Revenue Growth (2015-2020)
12 Global COVID-19 Recombinant Protein Vaccine Market Size Forecast (2021-2025)
12.1 Global COVID-19 Recombinant Protein Vaccine Market Size Forecast (2021-2025)
12.2 Global COVID-19 Recombinant Protein Vaccine Market Forecast by Regions (2021-2025)
12.3 North America COVID-19 Recombinant Protein Vaccine Revenue Market Forecast (2021-2025)
12.4 Europe COVID-19 Recombinant Protein Vaccine Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific COVID-19 Recombinant Protein Vaccine Revenue Market Forecast (2021-2025)
12.6 South America COVID-19 Recombinant Protein Vaccine Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa COVID-19 Recombinant Protein Vaccine Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global COVID-19 Recombinant Protein Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of COVID-19 Recombinant Protein Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global COVID-19 Recombinant Protein Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market COVID-19 Recombinant Protein Vaccine Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global COVID-19 Recombinant Protein Vaccine Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. GSK Corporate Information, Location and Competitors
Table 7. GSK COVID-19 Recombinant Protein Vaccine Major Business
Table 8. GSK COVID-19 Recombinant Protein Vaccine Total Revenue (USD Million) (2017-2018)
Table 9. GSK SWOT Analysis
Table 10. GSK COVID-19 Recombinant Protein Vaccine Product and Solutions
Table 11. GSK COVID-19 Recombinant Protein Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Novavax Corporate Information, Location and Competitors
Table 13. Novavax COVID-19 Recombinant Protein Vaccine Major Business
Table 14. Novavax COVID-19 Recombinant Protein Vaccine Total Revenue (USD Million) (2018-2019)
Table 15. Novavax SWOT Analysis
Table 16. Novavax COVID-19 Recombinant Protein Vaccine Product and Solutions
Table 17. Novavax COVID-19 Recombinant Protein Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Johnson & Johnson Corporate Information, Location and Competitors
Table 19. Johnson & Johnson COVID-19 Recombinant Protein Vaccine Major Business
Table 20. Johnson & Johnson COVID-19 Recombinant Protein Vaccine Total Revenue (USD Million) (2017-2018)
Table 21. Johnson & Johnson SWOT Analysis
Table 22. Johnson & Johnson COVID-19 Recombinant Protein Vaccine Product and Solutions
Table 23. Johnson & Johnson COVID-19 Recombinant Protein Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Suzhou Yuzhibo Biotechnology Corporate Information, Location and Competitors
Table 25. Suzhou Yuzhibo Biotechnology COVID-19 Recombinant Protein Vaccine Major Business
Table 26. Suzhou Yuzhibo Biotechnology COVID-19 Recombinant Protein Vaccine Total Revenue (USD Million) (2017-2018)
Table 27. Suzhou Yuzhibo Biotechnology SWOT Analysis
Table 28. Suzhou Yuzhibo Biotechnology COVID-19 Recombinant Protein Vaccine Product and Solutions
Table 29. Suzhou Yuzhibo Biotechnology COVID-19 Recombinant Protein Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Sanofi Corporate Information, Location and Competitors
Table 31. Sanofi COVID-19 Recombinant Protein Vaccine Major Business
Table 32. Sanofi COVID-19 Recombinant Protein Vaccine Total Revenue (USD Million) (2017-2018)
Table 33. Sanofi SWOT Analysis
Table 34. Sanofi COVID-19 Recombinant Protein Vaccine Product and Solutions
Table 35. Sanofi COVID-19 Recombinant Protein Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Clover Biopharmaceuticals Corporate Information, Location and Competitors
Table 37. Clover Biopharmaceuticals COVID-19 Recombinant Protein Vaccine Major Business
Table 38. Clover Biopharmaceuticals COVID-19 Recombinant Protein Vaccine Total Revenue (USD Million) (2017-2018)
Table 39. Clover Biopharmaceuticals SWOT Analysis
Table 40. Clover Biopharmaceuticals COVID-19 Recombinant Protein Vaccine Product and Solutions
Table 41. Clover Biopharmaceuticals COVID-19 Recombinant Protein Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Pukang Biologic Technology Corporate Information, Location and Competitors
Table 43. Pukang Biologic Technology COVID-19 Recombinant Protein Vaccine Major Business
Table 44. Pukang Biologic Technology COVID-19 Recombinant Protein Vaccine Total Revenue (USD Million) (2017-2018)
Table 45. Pukang Biologic Technology SWOT Analysis
Table 46. Pukang Biologic Technology COVID-19 Recombinant Protein Vaccine Product and Solutions
Table 47. Pukang Biologic Technology COVID-19 Recombinant Protein Vaccine Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Global COVID-19 Recombinant Protein Vaccine Revenue (Million USD) by Players (2015-2020)
Table 49. Global COVID-19 Recombinant Protein Vaccine Revenue Share by Players (2015-2020)
Table 50. Global COVID-19 Recombinant Protein Vaccine Revenue (Million USD) by Regions (2015-2020)
Table 51. Global COVID-19 Recombinant Protein Vaccine Revenue Market Share by Regions (2015-2020)
Table 52. North America COVID-19 Recombinant Protein Vaccine Revenue by Countries (2015-2020)
Table 53. North America COVID-19 Recombinant Protein Vaccine Revenue Market Share by Countries (2015-2020)
Table 54. Europe COVID-19 Recombinant Protein Vaccine Revenue (Million USD) by Countries (2015-2020)
Table 55. Asia-Pacific COVID-19 Recombinant Protein Vaccine Revenue (Million USD) by Countries (2015-2020)
Table 56. South America COVID-19 Recombinant Protein Vaccine Revenue by Countries (2015-2020)
Table 57. South America COVID-19 Recombinant Protein Vaccine Revenue Market Share by Countries (2015-2020)
Table 58. Middle East and Africa COVID-19 Recombinant Protein Vaccine Revenue (Million USD) by Countries (2015-2020)
Table 59. Middle East and Africa COVID-19 Recombinant Protein Vaccine Revenue Market Share by Countries (2015-2020)
Table 60. Global COVID-19 Recombinant Protein Vaccine Revenue (Million USD) by Type (2015-2020)
Table 61. Global COVID-19 Recombinant Protein Vaccine Revenue Share by Type (2015-2020)
Table 62. Global COVID-19 Recombinant Protein Vaccine Revenue Forecast by Type (2021-2025)
Table 63. Global COVID-19 Recombinant Protein Vaccine Revenue by Application (2015-2020)
Table 64. Global COVID-19 Recombinant Protein Vaccine Revenue Share by Application (2015-2020)
Table 65. Global COVID-19 Recombinant Protein Vaccine Revenue Forecast by Application (2021-2025)
Table 66. Global COVID-19 Recombinant Protein Vaccine Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. COVID-19 Recombinant Protein Vaccine Picture
Figure 2. Global COVID-19 Recombinant Protein Vaccine Revenue Market Share by Type in 2019
Figure 3. Being Developed Picture
Figure 4. Preclinical Picture
Figure 5. Clinical I Picture
Figure 6. Clinical II Picture
Figure 7. COVID-19 Recombinant Protein Vaccine Revenue Market Share by Application in 2019
Figure 8. Pharmaceutical And Biotechnology Companies Picture
Figure 9. Hospital Picture
Figure 10. Academic And Research Organizations Picture
Figure 11. Other Picture
Figure 12. Global COVID-19 Recombinant Protein Vaccine Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America COVID-19 Recombinant Protein Vaccine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe COVID-19 Recombinant Protein Vaccine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific COVID-19 Recombinant Protein Vaccine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America COVID-19 Recombinant Protein Vaccine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa COVID-19 Recombinant Protein Vaccine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global COVID-19 Recombinant Protein Vaccine Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global COVID-19 Recombinant Protein Vaccine Revenue Share by Players in 2019
Figure 20. Global Top 5 Players COVID-19 Recombinant Protein Vaccine Revenue Market Share in 2019
Figure 21. Global Top 10 Players COVID-19 Recombinant Protein Vaccine Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global COVID-19 Recombinant Protein Vaccine Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global COVID-19 Recombinant Protein Vaccine Revenue Market Share by Regions (2015-2020)
Figure 25. Global COVID-19 Recombinant Protein Vaccine Revenue Market Share by Regions in 2018
Figure 26. North America COVID-19 Recombinant Protein Vaccine Revenue and Growth Rate (2015-2020)
Figure 27. Europe COVID-19 Recombinant Protein Vaccine Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific COVID-19 Recombinant Protein Vaccine Revenue and Growth Rate (2015-2020)
Figure 29. South America COVID-19 Recombinant Protein Vaccine Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa COVID-19 Recombinant Protein Vaccine Revenue and Growth Rate (2015-2020)
Figure 31. North America COVID-19 Recombinant Protein Vaccine Revenue Market Share by Countries (2015-2020)
Figure 32. North America COVID-19 Recombinant Protein Vaccine Revenue Market Share by Countries in 2019
Figure 33. USA COVID-19 Recombinant Protein Vaccine Revenue and Growth Rate (2015-2020)
Figure 34. Canada COVID-19 Recombinant Protein Vaccine Revenue and Growth Rate (2015-2020)
Figure 35. Mexico COVID-19 Recombinant Protein Vaccine Revenue and Growth Rate (2015-2020)
Figure 36. Europe COVID-19 Recombinant Protein Vaccine Revenue Market Share by Countries (2015-2020)
Figure 37. Europe COVID-19 Recombinant Protein Vaccine Revenue Market Share by Countries in 2019
Figure 38. Germany COVID-19 Recombinant Protein Vaccine Revenue and Growth Rate (2015-2020)
Figure 39. UK COVID-19 Recombinant Protein Vaccine Revenue and Growth Rate (2015-2020)
Figure 40. France COVID-19 Recombinant Protein Vaccine Revenue and Growth Rate (2015-2020)
Figure 41. Russia COVID-19 Recombinant Protein Vaccine Revenue and Growth Rate (2015-2020)
Figure 42. Italy COVID-19 Recombinant Protein Vaccine Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific COVID-19 Recombinant Protein Vaccine Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific COVID-19 Recombinant Protein Vaccine Revenue Market Share by Countries in 2019
Figure 45. China COVID-19 Recombinant Protein Vaccine Revenue and Growth Rate (2015-2020)
Figure 46. Japan COVID-19 Recombinant Protein Vaccine Revenue and Growth Rate (2015-2020)
Figure 47. Korea COVID-19 Recombinant Protein Vaccine Revenue and Growth Rate (2015-2020)
Figure 48. India COVID-19 Recombinant Protein Vaccine Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia COVID-19 Recombinant Protein Vaccine Revenue and Growth Rate (2015-2020)
Figure 50. South America COVID-19 Recombinant Protein Vaccine Revenue Market Share by Countries (2015-2020)
Figure 51. South America COVID-19 Recombinant Protein Vaccine Revenue Market Share by Countries in 2019
Figure 52. Brazil COVID-19 Recombinant Protein Vaccine Revenue and Growth Rate (2015-2020)
Figure 53. Argentina COVID-19 Recombinant Protein Vaccine Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa COVID-19 Recombinant Protein Vaccine Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa COVID-19 Recombinant Protein Vaccine Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia COVID-19 Recombinant Protein Vaccine Revenue and Growth Rate (2015-2020)
Figure 57. UAE COVID-19 Recombinant Protein Vaccine Revenue and Growth Rate (2015-2020)
Figure 58. Egypt COVID-19 Recombinant Protein Vaccine Revenue and Growth Rate (2015-2020)
Figure 59. South Africa COVID-19 Recombinant Protein Vaccine Revenue and Growth Rate (2015-2020)
Figure 60. Global COVID-19 Recombinant Protein Vaccine Revenue Share by Type (2015-2020)
Figure 61. Global COVID-19 Recombinant Protein Vaccine Revenue Share by Type in 2019
Figure 62. Global COVID-19 Recombinant Protein Vaccine Market Share Forecast by Type (2021-2025)
Figure 63. Global Being Developed Revenue Growth Rate (2015-2020)
Figure 64. Global Preclinical Revenue Growth Rate (2015-2020)
Figure 65. Global Clinical I Revenue Growth Rate (2015-2020)
Figure 66. Global Clinical II Revenue Growth Rate (2015-2020)
Figure 67. Global COVID-19 Recombinant Protein Vaccine Revenue Share by Application (2015-2020)
Figure 68. Global COVID-19 Recombinant Protein Vaccine Revenue Share by Application in 2019
Figure 69. Global COVID-19 Recombinant Protein Vaccine Market Share Forecast by Application (2021-2025)
Figure 70. Global Pharmaceutical And Biotechnology Companies Revenue Growth Rate (2015-2020)
Figure 71. Global Hospital Revenue Growth Rate (2015-2020)
Figure 72. Global Academic And Research Organizations Revenue Growth Rate (2015-2020)
Figure 73. Global Other Revenue Growth Rate (2015-2020)
Figure 74. Global COVID-19 Recombinant Protein Vaccine Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global COVID-19 Recombinant Protein Vaccine Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global COVID-19 Recombinant Protein Vaccine Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America COVID-19 Recombinant Protein Vaccine Revenue Market Forecast (2021-2025)
Figure 78. Europe COVID-19 Recombinant Protein Vaccine Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific COVID-19 Recombinant Protein Vaccine Revenue Market Forecast (2021-2025)
Figure 80. South America COVID-19 Recombinant Protein Vaccine Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa COVID-19 Recombinant Protein Vaccine Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
B型肝炎ワクチン（組換え）の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Hepatitis B Vaccine (Recombinant) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain o…- 新型コロナウイルス感染症RNAワクチンの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The COVID-19 RNA Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- 新型コロナウイルス感染症DNAワクチンの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The COVID-19 DNA Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- 組換えヒトタンパク質の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Recombinant Human Proteins market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Recombinant Human …
- アデノウイルスベクターワクチンの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Adenovirus Vector Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…